Rituximab in the Treatment of Graves' Disease

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

October 31, 2006

Conditions

Graves´ DiseaseThyroid Associated Ophthalmopathy

Interventions

DRUG

Methimazole

DRUG

Rituximab

BIOLOGICAL

Immunization with various vaccines

Trial Locations (2)

Department of Endocrinology, Odense University Hospital, Odense

Department of Hematology, Odense University Hospital, Odense

All Listed Sponsors

lead

Odense University Hospital

OTHER

NCT00150111 - Rituximab in the Treatment of Graves' Disease | Biotech Hunter | Biotech Hunter